Peer Review History

Original SubmissionNovember 19, 2020
Decision Letter - Mauro Sanchez, Editor, Gerson Oliveira Penna, Editor

Dear Msc Urgesa,

Thank you very much for submitting your manuscript "Evidence for hidden leprosy in the post-elimination era in a high leprosy endemic setting, Eastern Ethiopia: application of active case finding and contact screening" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

Please pay special attention to recommendations regarding formatting, language, structure and length of the discussion, the concept of elimination of leprosy and limitations of the study.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Mauro Sanchez, ScD

Associate Editor

PLOS Neglected Tropical Diseases

Gerson Penna

Deputy Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: This is a descriptive study and investigatory of nature. Although quite a large population (app. 16,000) was screened for signs and symptoms of leprosy, in the end only 15 (hidden) cases were confirmed. This is important information from a policy point of view, but the low numbers make it difficult to perform statistical analyses satisfactorily. In fact, there are no statistically significant differences shown in any of the analyses at the p=0.05 level.

Reviewer #2: This study is observational epidemiologic description

Reviewer #3: See attached document

Reviewer #4: Yes. I just recommend inserting a map to locate the location of kebeles on the Ethiopian map for the international reader.

In the future, I recommend doing a case-control study (with neighborhood controls) to better estimate the contribution of these associated factors to the occurrence of the disease in this area.

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: Table 1 is difficult to read. Firstly, numbers (N) and (%) are given in the same column, these should be in separate columns. Secondly, 1 decimal for percentages is sufficient. Thirdly, total N should show 100% in each row every time. Or else put the total first in a column and give the total of each category in a row underneath. So:

Sex Negative Positive

Male 145 (55.3%) 134 (92.4%) 11 (7.6%)

Female 177 (44.7%)

Total 262 (100%)

Age category (in years)

<15

etc.

Information on the part on the hidden prevalence is divided between text (end page 12 and page 13) and Figure 1. This is confusing. The figure does not add much extra information at all and this part can be best summarized in a table, bringing all information comprehensively together.

Table 2 is not necessary. The 4 lines (250-253) on page 13 say it all...

Reviewer #2: well presented and discussed

Reviewer #3: See attached document

Reviewer #4: - For the level of education only have these two possibilities? Wouldn't it be interesting to include, classify "literates" in the education levels, covering other school grades, including people who have completed regular education or higher education?

- When discussing the results, I consider it delicate to make this comparison with studies carried out in other countries with a high leprosy burden. And even if not all of the cases were multibacillary, it was a high percentage in the study in question (lines 306 - 312).

- Regarding the information on lines 334 and 335, was it really a failure of the HEWs to identify these co-prevalent cases or because these contacts were not at home at the time of the first visit?

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: The discussion section is very lengthy and can be shortened by at least a third. The strengths and limitations usually come before the final conclusion. Most part of the conclusion paragraph are actually recommendations and could be formulated separately under a heading recommendations.

Reviewer #2: relevant and in accordance to tile and abstract

Reviewer #3: See attached document

Reviewer #4: - In lines 200 and 201 it was mentioned that "While individual confirmed as leprosy case initiated treatment, suspects with other skin diseases were linked to the nearby health facility for clinical management." On lines 275 and 276 "Another challenge in this study was insufficient or shortage of MDT for leprosy treatment. "How was this important ethical issue and articulation with health services resolved? Were all the cases diagnosed in the research treated as mentioned in the methodology? consent that participants signed? Make it clearer on the paper.

- Lines 358 e 359 - I think that this discussion can be further developed in the light of the current literature on the social determinants of the occurrence of leprosy and considering the limitations of the study and data analysis

- I suggest adding recommendations for other research that can complement the identified results.

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: Indicate once in the text that the term for village in Ethiopia is kebele, but otherwise use the familiar English term village throughout the manuscript.

Reviewer #2: yes

Reviewer #3: (No Response)

Reviewer #4: - Attention to the formatting details of paragraphs, tables and graph.

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: Although this paper is relevant for Ethiopia from a leprosy control policy point of view, its scientific (epidemiological) merit is rather limited due to the low numbers and very descriptive nature. It would be better suited for a specific leprosy journal, such as Leprosy Review. In any case, the manuscript can be shortened and improved (see specific comments). Also, it needs a very thorough English language edit. This is a major limitation of the current manuscript.

Reviewer #2: clear

Reviewer #3: See attached document

Reviewer #4: This issue of elimination is controversial because this indicator is based on a prevalence calculated based on cases with an active record, under treatment - when in fact, case detection and hidden prevalence should be considered. In the introduction and discussion I recommend doing a more in-depth reflection on this "post-elimination" era and what it really takes and what it means to achieve these leprosy elimination goals. How to consider that a disease has been eliminated, as mentioned in lines 71 to 75, if the indicator that represents this elimination disregards the hidden prevalence? I recommend this among other references:Lockwood, DN; Shetty, V; Penna, GO (2014) Hazards of setting tar-gets to eliminate disease: lessons from the leprosy elimination cam-paign. BMJ (Clinical research ed), 348. g1136. ISSN 0959-8138 DOI:https://doi.org/10.1136/bmj.g1136

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Carlos Franco-Paredes

Reviewer #3: No

Reviewer #4: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see https://journals.plos.org/plosntds/s/submission-guidelines#loc-methods

Revision 1

Attachments
Attachment
Submitted filename: Response to reviewers.doc
Decision Letter - Mauro Sanchez, Editor, Gerson Oliveira Penna, Editor

Dear Dr Urgesa,

We are pleased to inform you that your manuscript 'Evidence for hidden leprosy in a high leprosy-endemic setting, Eastern Ethiopia: the application of active case-finding and contact screening' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Mauro Sanchez, ScD

Associate Editor

PLOS Neglected Tropical Diseases

Gerson Penna

Deputy Editor

PLOS Neglected Tropical Diseases

***********************************************************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: The authors have adjusted the methods section well according to reviewer suggestions.

Reviewer #3: (No Response)

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: The presentation of results has improved significantly according to reviewer suggestions.

Reviewer #3: (No Response)

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: The discussion and conclusions have improved markedly and are now concise and to the point.

Reviewer #3: (No Response)

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: Accept

Reviewer #3: Line 190 "tenderness and the presence of acid-fast bacilli in a slit-skin smear" needs a little correction.

The presence of bacilli is not necessary to establish the diagnosis of leprosy. To better clarify, as a suggestion:

"with or without tenderness and with or without the presence of acid-fast bacilli in a slit-skin smear."

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: I think that the revised manuscript now better highlights the fact that unexpected relatively high numbers of new cases are found through active case finding in endemic districts and its relevance for leprosy control measures. There is now less (unnecessary) emphasis on statistical analyses, which distracted from the main message of the paper.

Reviewer #3: Congratulations on the excellent work.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: No

Formally Accepted
Acceptance Letter - Mauro Sanchez, Editor, Gerson Oliveira Penna, Editor

Dear Mr URGESA,

We are delighted to inform you that your manuscript, "Evidence for hidden leprosy in a high leprosy-endemic setting, Eastern Ethiopia: the application of active case-finding and contact screening," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .